Page 4 - Orally Disintegrating Tablets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Reddy’s announces launch of Lansoprazole DR Orally Disintegrating Tablets in US market
Hyderabad, Feb 21(UNI) Dr Reddy’s Laboratories Limited, along with its subsidiaries, together on Monday announced the launch of Lansoprazole DR Orally Disintegrating Tablets a therapeutic equivalent generic version of Prevacid SoluTab Delayed- Release Orally Disintegrating Tablets, 15 mg and 30 mg, approved by the U.S. Food and Drug Administration (USFDA).
The Prevacid brand and generic had U.S. sales of approximately USD 87 million MAT for the most recent twelve months ending in December 2020 according to IMS Health, a company release here said.
Dr Reddy’s Lansoprazole DR Orally Disintegrating Tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10). ....

Andhra Pradesh , Dr Reddy Laboratories , Drug Administration , Disintegrating Tablets , Laboratories Limited , Prevacid Solutab , Orally Disintegrating Tablets , ஆந்திரா பிரதேஷ் , டாக்டர் சிவப்பு ஆய்வகங்கள் , ஆய்வகங்கள் வரையறுக்கப்பட்டவை ,